LPARFS
JSPR icon

Leverage Partners Absolute Return Fund SPC’s Jasper Therapeutics JSPR Stock Holding History

Leverage Partners Absolute Return Fund SPC’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,500
Closed -$815K – 102
2021
Q3 		$815K Buy
+1,500
New +$153K 0.78% 44

Other funds holding JSPR

QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Leverage Partners Absolute Return Fund SPC's JSPR Position: Q4 2021 in Review

Leverage Partners Absolute Return Fund SPC sold out of Jasper Therapeutics (JSPR) in Q4 2021, closing a stake of 1,500 shares — an estimated $815K sold.

Leverage Partners Absolute Return Fund SPC first reported a position in JSPR in Q3 2021 and held it in 1 quarter. The position peaked at $815K in Q3 2021. 25 funds tracked by Wall St. Rank hold JSPR as of Q4 2021.

  • Leverage Partners Absolute Return Fund SPC reported no remaining Jasper Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Leverage Partners Absolute Return Fund SPC sold 1,500 Jasper Therapeutics shares in Q4 2021, an estimated $815K.
  • Leverage Partners Absolute Return Fund SPC first reported a position in Jasper Therapeutics in Q3 2021 and held it in 1 quarter.
  • Leverage Partners Absolute Return Fund SPC's Jasper Therapeutics position peaked at $815K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2021.

Based on Leverage Partners Absolute Return Fund SPC's 13F filing for Q4 2021, filed 11 Feb 2022.